TM Capital assisted the Board of Directors of Allied Research Corporation (AMEX) in connection with a proxy contest in which all of Allied’s directors were successfully re-elected
TM Capital assisted the Board of Directors of TAB Products, Inc. (AMEX) in adopting a shareholder’s rights plan.
TM Capital assisted the Board of Directors of Atlantic Marine Holding Company in the evaluation of the acquisition by J.F. Lehman & Company
TM Capital served as financial advisor to BlueLinx Holdings Inc. (NYSE:BXC) in connection with its proposed 1 for 10 reverse stock split
TM Capital assisted the Board of Directors of Teknowledge, Inc. (NASDAQ) in adopting a shareholder’s rights plan.
TM Capital served as financial advisor to a bank group led by Fleet National Bank regarding a senior credit facility with PSC Inc. (NASDAQ)
TM Capital was retained by the Board of Directors of Omega Protein (NYSE) to act as financial advisor in connection with Omega’s $47.5 million share repurchase from Zapata Corporation (NYSE)
TM Capital served as exclusive financial advisor to RTC, Inc. regarding an equity valuation and share repurchase
TM Capital advised the Board of Directors of Magellan Petroleum Corp. (NASD) in its successful defense against an unsolicited tender offer by SAGASCO Holdings Ltd. of Australia
TM Capital completed the sale of SteriGenics International, Inc. (NASDAQ) to Ion Beam Applications s.a. of Belgium for $214 million in cash